Literature DB >> 15768198

Reproducibility of methods for assessing baroreflex sensitivity and temporal QT variability in end-stage renal disease and healthy subjects.

Sinsia A Gao1, Mats Johansson, Anna Hammarén, Martin Nordberg, Peter Friberg.   

Abstract

Spontaneous baroreflex sensitivity (BRS), the reflex heart rate modulation in response to blood pressure changes (predominantly an index of cardiac vagal activity) and temporal QT variability (an index of myocardial repolarization) have been demonstrated to convey important prognostic information. The information about reproducibility of BRS and temporal QT variability is limited and there is lack of information regarding patients with cardiovascular diseases. We investigated reproducibility of spontaneous BRS using the sequence technique and temporal QT variability index (QTVI) in terms of intra-, interexaminer and within-subject variability in end-stage renal disease patients (ESRD, n=17, age 55+/-14 years) and healthy subjects (HS, n=29, age 32+/-12 years, P<0.01). ECG and blood pressure (Portapres) were recorded on two separate days and BRS and QTVI were evaluated by two independent examiners. The mean heart rate was similar in ESRD patients in comparison to healthy controls, whereas the mean arterial pressure was 13 % higher in ESRD patients (P<0.01). Spontaneous BRS was 62% lower (P<0.01) and QTVI was 41% higher in ESRD patients (P<0.01) compared to healthy subjects, respectively. Coefficient of variation (CV) of within-subject reproducibility of BRS and QTVI measurements was moderate (BRS: 33 % for ESRD, 27% for HS; QTVI: 40% for ESRD, 18% for HS). The 95% limit of within-subject reproducibility of BRS measurements was 3.8 ms/mm Hg for ESRD patients and 8.1 ms/mm Hg for healthy subjects; whereas the 95% limit of reproducibility of within-subject reproducibility of QTVI measurements was 0.73 for ESRD patients and 0.55 for healthy subjects. Concordance correlation coefficients of within-subject variability of BRS and QTVI were between 0.74 and 0.83 in both groups. CV of intra- and inter-examiner reproducibility of BRS and QTVI measurements in both groups ranged between 1 and 11%. In conclusion, the intra- and inter-examiner reproducibility/agreement of BRS and QTVI were high, whereas the within-subject reproducibility of these two methods was moderate, in both ESRD patients and healthy subjects. Thus, small differences in BRS and QTVI in longitudinal/interventional studies should be interpreted with caution.

Entities:  

Mesh:

Year:  2005        PMID: 15768198     DOI: 10.1007/s10286-005-0224-4

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  23 in total

Review 1.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

2.  The reproducibility of cardiac baroreceptor activity assessed non-invasively by spectral sequence techniques.

Authors:  S L Dawson; T G Robinson; J H Youde; M A James; A Martin; P Weston; R Panerai; J F Potter
Journal:  Clin Auton Res       Date:  1997-12       Impact factor: 4.435

3.  Evaluation of reproducibility of spontaneous baroreflex sensitivity at rest and during laboratory tests.

Authors:  F Iellamo; J M Legramante; G Raimondi; F Castrucci; M Massaro; G Peruzzi
Journal:  J Hypertens       Date:  1996-09       Impact factor: 4.844

4.  Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats.

Authors:  G Bertinieri; M Di Rienzo; A Cavallazzi; A U Ferrari; A Pedotti; G Mancia
Journal:  Am J Physiol       Date:  1988-02

5.  A concordance correlation coefficient to evaluate reproducibility.

Authors:  L I Lin
Journal:  Biometrics       Date:  1989-03       Impact factor: 2.571

6.  Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke.

Authors:  Thompson G Robinson; Suzanne L Dawson; Penelope J Eames; Ronney B Panerai; John F Potter
Journal:  Stroke       Date:  2003-02-27       Impact factor: 7.914

7.  A new approach to analysis of the arterial baroreflex.

Authors:  G Bertinieri; M di Rienzo; A Cavallazzi; A U Ferrari; A Pedotti; G Mancia
Journal:  J Hypertens Suppl       Date:  1985-12

8.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

9.  Noninvasive assessment of baroreflex control in borderline hypertension. Comparison with the phenylephrine method.

Authors:  L L Watkins; P Grossman; A Sherwood
Journal:  Hypertension       Date:  1996-08       Impact factor: 10.190

10.  Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death.

Authors:  W L Atiga; H Calkins; J H Lawrence; G F Tomaselli; J M Smith; R D Berger
Journal:  J Cardiovasc Electrophysiol       Date:  1998-09
View more
  8 in total

Review 1.  Predicting cardiovascular risk--the madness is in the methods.

Authors:  Mark W Chapleau
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

Review 2.  Towards a better understanding of QT interval variability.

Authors:  Larisa G Tereshchenko; Ronald D Berger
Journal:  Ther Adv Drug Saf       Date:  2011-12

Review 3.  Baroreflex dysfunction in chronic kidney disease.

Authors:  Manpreet Kaur; Dinu S Chandran; Ashok Kumar Jaryal; Dipankar Bhowmik; Sanjay Kumar Agarwal; Kishore Kumar Deepak
Journal:  World J Nephrol       Date:  2016-01-06

4.  Hydration assessment using the cardiovascular response to standing.

Authors:  Samuel N Cheuvront; Brett R Ely; Robert W Kenefick; Mark J Buller; Nisha Charkoudian; Michael N Sawka
Journal:  Eur J Appl Physiol       Date:  2012-04-06       Impact factor: 3.078

5.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

6.  Prognostic indicators of cardiovascular risk in renal disease.

Authors:  Cara M Hildreth
Journal:  Front Physiol       Date:  2012-01-12       Impact factor: 4.566

7.  Baroreflex sensitivity measured by spectral and sequence analysis in cerebrovascular disease : methodological considerations.

Authors:  Paul Johnson; Angela Shore; John Potter; Ronney Panerai; Martin James
Journal:  Clin Auton Res       Date:  2006-06-12       Impact factor: 5.625

8.  Executive Cognitive Functioning and Cardiovascular Autonomic Regulation in a Population-Based Sample of Working Adults.

Authors:  Cecilia U D Stenfors; Linda M Hanson; Töres Theorell; Walter S Osika
Journal:  Front Psychol       Date:  2016-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.